New global trial testing oral therapy for MS spasticity
UC expert featured in MS News Today article
The University of Cincinnati's Shahla Hosseini, MD, PhD, was featured in a Multiple Sclerosis (MS) News Today article discussing a new international clinical trial testing an oral drug that enhances naturally occurring molecules in the body to help muscles relax as a treatment for spasticity in patients with MS.
Many patients with MS experience spasticity, which causes muscles to resist being stretched, leading to pain, impaired function, decreased mobility and poorer quality of life.
“Physicians who treat muscle spasticity have a limited number of medications from which to choose. In the past 20 to 30 years, we haven’t seen development of new effective oral medications to treat spasticity in the United States,” said Hosseini, adjunct associate professor of Physical Medicine and Rehabilitation in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Health physician. “The majority of the currently available oral medications have side effects like drowsiness, which limits their usefulness during the daytime, and so we really need a new effective treatment for spasticity that’s better tolerated by patients.”
The body naturally produces molecules called endocannabinoids that help muscles relax and play a role in other functions, including regulating mood, pain and sleep, Hosseini explained. The trial drug is designed to inhibit two enzymes that break down endocannabinoids, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), allowing the endocannabinoids to help regulate the overly reactive spastic muscles.
Read the MS News Today article.
Featured photo at top of a person with knee stiffness. Photo/PonyWang/iStock Photo.
Related Stories
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.
'Be human in it': UC College of Medicine welcomes Class of 2030 at 31st White Coat Ceremony
August 4, 2026
The University of Cincinnati College of Medicine welcomed 185 first-year medical students in the Class of 2030 at the 31st annual White Coat Ceremony.
UC-built detector at CERN looks for enticing evidence to explain dark matter
August 4, 2026
A physicist from the University of Cincinnati and his research partners from around the world conducted an experiment at CERN’s Large Hadron Collider in Switzerland to look for evidence that might help explain one of science’s most baffling questions: dark matter.